Selective noradrenaline reuptake inhibitors for schizophrenia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Selective Noradrenaline Reuptake Inhibitors for Schizophrenia." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432614/all/images/ios-appstore-badge.png. Accessed 01 May 2024.
Selective noradrenaline reuptake inhibitors for schizophrenia. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432614/all/images/ios-appstore-badge.png. Accessed May 1, 2024.
Selective noradrenaline reuptake inhibitors for schizophrenia. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432614/all/images/ios-appstore-badge.png
Selective Noradrenaline Reuptake Inhibitors for Schizophrenia [Internet]. In: Cochrane Abstracts. [cited 2024 May 01]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432614/all/images/ios-appstore-badge.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Selective noradrenaline reuptake inhibitors for schizophrenia
ID - 432614
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432614/all/images/ios-appstore-badge.png
DB - Evidence Central
DP - Unbound Medicine
ER -